DARE
Dare Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.72
+1.11%Margins
Gross margin
-89.5%
EBITDA margin
-672.6%
EBIT margin
-813.4%
Net margin
-804.4%
FCF margin
-860.6%
1961.6%
Return on equity
-49.1%
Return on assets
-179.1%
Return on invested capital
0.05x
Asset turnover
-$11.3M
Cash from operations
$0.65
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026